Evidence map›Paper›PMID 22225849›Full record

ArticleBiological psychiatry2012

Comparison of the effects of estradiol and progesterone on serotonergic function.

Saloua Benmansour, Rami S Weaver, Amanda K Barton, Opeyemi S Adeniji, Alan Frazer

Abstract readComparative Study
In one paragraph

Article in Biological psychiatry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 70 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Emerging Perspectives on the Impact of Diabetes Mellitus and Anti-Diabetic Drugs on Premenstrual Syndrome. A Narrative Review.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Sex differences in fear extinction.Neuroscience and biobehavioral reviews · 2019
    Review
  14. Review
  15. Serum levels of GPER-1 in euthymic bipolar patients.Neuropsychiatric disease and treatment · 2018
    Article
  16. Increased Serum G Protein-coupled Estrogen Receptor 1 Levels and Its Diagnostic Value in Drug Naïve Patients with Major Depressive Disorder.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2017
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Saloua BenmansourDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, 78229-3900, USA. benmansour@uthscsa.edu
Rami S Weaver
Amanda K Barton
Opeyemi S Adeniji
Alan Frazer
The University of Texas Health Science Center at San Antonio · USSouth Texas Veterans Health Care System · US

Funding

5-HT transporter function: Interaction of antidepressants and hormonesR01MH090386 · NIMH · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI FRAZER, ALAN · 2010 to 2014
$1.6M
Selective negative allosteric modulators of alpha 5-GABAA receptors: novel psychotherapeutic drugsI01BX000559 · VA · SOUTH TEXAS VETERANS HEALTH CARE SYSTEM · PI MORILAK, DAVID A · 2011 to 2025
–
BLRD VA I01 BX000559NIMH NIH HHS MH090386NIMH NIH HHS R01 MH090386
6 · The paper itself

Abstract

backgroundOvarian hormones may contribute to the vulnerability to depression, as well as to the response to antidepressants (ADs). Previously, we reported that acute systemic treatment with estradiol or progesterone blocked the ability of the selective serotonin reuptake inhibitor, fluvoxamine, to inhibit serotonin transporter function in ovariectomized rats. In this study, behavioral consequences, as well as receptor mechanisms underlying these hormonal effects, were investigated.

methodsUsing the forced swimming test, the acute effect of estradiol and/or progesterone on fluvoxamine's AD-like effects was investigated. Using in vivo chronoamperometry, the effect of local application of estradiol or progesterone into the hippocampus of ovariectomized rats on serotonin (5-HT) clearance, as well as on the ability of fluvoxamine to slow 5-HT clearance, were investigated.

resultsThe decreased immobility and increased swimming caused by fluvoxamine in the forced swimming test was blocked in rats treated with estradiol and/or progesterone. Local application of estradiol, but not progesterone, slowed 5-HT clearance and both hormones blocked the ability of fluvoxamine to slow 5-HT clearance. Use of hormone receptor agonists and antagonists, revealed that the effects of estradiol are mediated by activation of membrane, as well as nuclear estrogen receptors (ER). The AD-like effect of estradiol involved ER beta and G-protein coupled receptor 30, whereas its blockade of fluvoxamine's effects was ER alpha-mediated. The effects of progesterone occurred solely by activation of intracellular progesterone receptors.

conclusionsTargeting of ER beta or G-protein coupled receptor 30 might reveal a strategy to permit beneficial effects of estrogen without its deleterious effect on selective serotonin reuptake inhibitor efficacy.

Indexed as

AnimalsEstradiolFemaleFluvoxamineHippocampusImmobility Response, TonicMicroinjectionsProgesteroneRatsRats, Sprague-DawleyReceptors, EstrogenReceptors, ProgesteroneSerotoninSwimmingEstradiolFluvoxamineProgesteroneReceptors, EstrogenReceptors, ProgesteroneSerotonin

Identifiers

PMID22225849
PMCPMC3307822
OpenAlexW2151358022

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.